G. Luo

发表

Quantum dots in cancer therapy

Jiang Long, Jin Xu, Chen Liu, 2012, Expert opinion on drug delivery.

Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients

Xianjun Yu, Chen Liu, Q. Ni, 2020, Cancer management and research.

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas

Xianjun Yu, Chen Liu, Q. Ni, 2020, Experimental and therapeutic medicine.

Pilot study of targeting magnetic carbon nanotubes to lymph nodes.

Dong Yang, Jianhua Hu, Feng Yang, 2009, Nanomedicine.

Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma.

Xianjun Yu, Chen Liu, Q. Ni, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN

Xianjun Yu, Chen Liu, Jin Xu, 2019, World Journal of Surgical Oncology.

Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma

Yusheng Chen, Xuan Lin, Chen Liu, 2022, Oncogenesis.

The role of necroptosis in cancer biology and therapy

Chao Yang, Xianjun Yu, Chen Liu, 2019, Molecular Cancer.

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Zuqiang Liu, J. Long, Xianjun Yu, 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Preoperative diagnosis of nonfunctioning pancreatic neuroendocrine tumors

Feng Yang, Ji Li, Lie Yao, 2011, Medical oncology.

Hexokinase 2 dimerization and interaction with voltage‐dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer

Xianjun Yu, Chen Liu, Chao Yang, 2019, Cancer medicine.

Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer

Zuqiang Liu, J. Long, Xianjun Yu, 2017, Annals of Surgical Oncology.

Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer.

Xianjun Yu, Chen Liu, Q. Ni, 2017, International Journal of Oncology.

Distribution of Lewis and Secretor polymorphisms and corresponding CA19‐9 antigen expression in a Chinese population

R. Lu, J. Long, Xianjun Yu, 2017, FEBS open bio.

Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors

Xianjun Yu, Chen Liu, Q. Ni, 2020, Pancreas.

Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasms

Lei Wang, Q. Ni, G. Luo, 2022, Endocrine.

Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors.

Jie Chen, Wenquan Wang, H. Gao, 2017, Oncology letters.

Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China.

Bo-Heng Zhang, J. Long, Xianjun Yu, 2017, Oncology letters.

Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.

elliot k fishman, A. Javed, L. Shen, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Revised nodal stage for pancreatic neuroendocrine tumors.

B. Zhang, H. Gao, J. Long, 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China.

Chunxiao Wu, J. Long, Xianjun Yu, 2014, Cancer letters.

Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer.

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Abstract. Carbohydrate antigen 19-9 (CA19-9) is the most important biomarker for pancreatic cancer. Approximately 5-10% of individuals are Lewis antigen negative with scarce secretion of CA19‐9 and fucosylation deficiency. However, the characteristics of Lewis-negative pancreatic cancer are uniden-

Xianjun Yu, Chen Liu, Q. Ni, 2020 .

Application of “Papillary-Like Main Pancreatic Duct Invaginated” Pancreaticojejunostomy for Normal Soft Pancreas Cases

Chun-tao Wu, J. Long, Xianjun Yu, 2013, Scientific Reports.

Fibrinogen/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms

Xianjun Yu, Chen Liu, G. Luo, 2021, Cancer management and research.

CMAR_A_275173 107..115

Xianjun Yu, Chen Liu, G. Luo, 2021 .

Role of Epidermal Growth Factor Receptor Expression on Patient Survival in Pancreatic Cancer: A Meta-Analysis

Jiang Long, Jin Xu, Chen Liu, 2011, Pancreatology.

Contents Vol. 11, 2011

E. Achten, J. Neoptolemos, D. Yadav, 2012, Pancreatology.

LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.

Feng Yang, W. Lu, C. Zhan, 2010, International journal of pharmaceutics.

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2020, Journal of Hematology & Oncology.

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.

A. Warshaw, R. Lu, J. Long, 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

An integrative theory for cancer (Review)

Na Liu, G. Luo, 2018, International journal of molecular medicine.

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients

Xianjun Yu, Liang Liu, Chen Liu, 2017, International journal of cancer.

Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer

Xianjun Yu, Chen Liu, Chao Yang, 2020, Annals of Surgical Oncology.

Pancreatic cancer: BRCA mutation and personalized treatment

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Expert review of anticancer therapy.

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.

Xianjun Yu, Chen Liu, Q. Ni, 2020, Biochimica et biophysica acta. Reviews on cancer.

(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.

Dan Huang, Zuqiang Liu, J. Long, 2014, International journal of oncology.

F-FDG PET / CT can be used to detect non-functioning pancreatic neuroendocrine tumors

Dan Huang, Zuqiang Liu, J. Long, 2014 .

Stroma and pancreatic ductal adenocarcinoma: an interaction loop.

J. Long, Xianjun Yu, Chen Liu, 2012, Biochimica et biophysica acta.

Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome Sequencing

J. Long, Xianjun Yu, Chen Liu, 2017, International journal of molecular sciences.

The role of necroptosis in cancer biology and therapy

Chao Yang, Xianjun Yu, Chen Liu, 2019, Molecular Cancer.

Energy sources identify metabolic phenotypes in pancreatic cancer.

Xianjun Yu, Liang Liu, S. Ji, 2016, Acta biochimica et biophysica Sinica.

Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer

Zhao-You Tang, Wen-quan Wang, Hua-Xiang Xu, 2013, PloS one.

Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma

Kaixing Ai, G. Luo, Rundong Zhang, 2018, Journal of Cancer.

Pancreatic cancer: gene therapy approaches and gene delivery systems

C. Jin, D. Fu, Jin Xu, 2010, Expert opinion on biological therapy.

Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma

Chao Yang, Xianjun Yu, Chen Liu, 2018, Cancer Immunology, Immunotherapy.

Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy

Zuqiang Liu, J. Long, Xianjun Yu, 2014, Annals of Surgical Oncology.

High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour

Xianjun Yu, Chen Liu, Q. Ni, 2020, Endocrine.

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions

Xianjun Yu, Chen Liu, G. Luo, 2018, Journal of Hematology & Oncology.

Prognosis of distal pancreatic cancers controlled by stage

Xianjun Yu, Chen Liu, Q. Ni, 2020, Experimental and therapeutic medicine.

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients

Xianjun Yu, Chen Liu, Jin Xu, 2020, Cancer medicine.

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.

Zuqiang Liu, J. Long, Xianjun Yu, 2017, Cancer letters.

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Drug design, development and therapy.

KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer.

Xianjun Yu, Chen Liu, Jin Xu, 2019, Cancer letters.

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer

R. Lu, J. Long, Xianjun Yu, 2017, Annals of surgery.

Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients.

Zuqiang Liu, J. Long, Xianjun Yu, 2017, Oncology letters.

Lewis antigen-negative pancreatic cancer: An aggressive subgroup

Xianjun Yu, Chen Liu, Q. Ni, 2020, International journal of oncology.

Developmental plasticity of stem cells and diseases.

J. Long, Xianjun Yu, Chen Liu, 2010, Medical hypotheses.

Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors

Xiaowu Xu, Xianjun Yu, S. Ji, 2020, Pancreas.

Primary Pancreatic Lymphoma

Feng Yang, C. Jin, D. Fu, 2009, Tumori.

MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.

Xianjun Yu, Chen Liu, G. Luo, 2018, Cancer letters.

Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors.

Jie Chen, J. Long, Xianjun Yu, 2017, Oncology letters.

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.

Zuqiang Liu, J. Long, Xianjun Yu, 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer

Zuqiang Liu, Chun-tao Wu, J. Long, 2014, BioMed research international.

CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer

Zuqiang Liu, J. Long, Xianjun Yu, 2013, Journal of Gastrointestinal Surgery.

Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas

Xianjun Yu, Chen Liu, G. Luo, 2021, World Journal of Surgical Oncology.

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma

Yusheng Chen, Xianjun Yu, Chen Liu, 2022, Journal of immunology research.

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.

Zuqiang Liu, J. Long, Xianjun Yu, 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes.

Dan Huang, Xianjun Yu, Chen Liu, 2019, Pancreas.

Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients

Q. Ni, G. Luo, Zhiwen Xiao, 2023, Endocrine.

The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

J. Long, Xianjun Yu, Liang Liu, 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

The CRP/Albumin Ratio Predicts Survival And Monitors Chemotherapeutic Effectiveness In Patients With Advanced Pancreatic Cancer

Xianjun Yu, Chen Liu, Q. Ni, 2019, Cancer management and research.

Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.

J. Long, Xianjun Yu, Liang Liu, 2014, Hepatobiliary & pancreatic diseases international : HBPD INT.

Predictive Values of Preoperative Markers for Resectable Pancreatic Body and Tail Cancer Determined by MDCT to Detect Occult Metastases

Xianjun Yu, Chen Liu, G. Luo, 2021, World Journal of Surgery.

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer

Dan Huang, Zuqiang Liu, J. Long, 2016, International journal of molecular sciences.

Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma

J. Long, Xianjun Yu, Chen Liu, 2018, Pancreas.

The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.

Z. Wang, G. Luo, H. Cheng, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR.

Chao Yang, Xianjun Yu, Chen Liu, 2020, Acta biochimica et biophysica Sinica.

Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties.

Zuqiang Liu, J. Long, Xianjun Yu, 2013, International journal of oncology.

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

Xianjun Yu, Chen Liu, Q. Ni, 2020, Cancer control : journal of the Moffitt Cancer Center.

Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?

Zuqiang Liu, D. Fu, J. Long, 2016, Oncotarget.

High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2021, World Journal of Surgical Oncology.

Development of a unique mouse model for pancreatic cancer lymphatic metastasis.

J. Long, Xianjun Yu, Chen Liu, 2012, International journal of oncology.

EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms

A. Warshaw, J. Strosberg, R. Lu, 2023, International journal of cancer.

Critical role of KRAS mutation in pancreatic ductal adenocarcinoma

Xianjun Yu, Chen Liu, Q. Ni, 2018, Translational Cancer Research.

Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer

Wei Wu, R. Lu, Xianjun Yu, 2023, Discover Oncology.

Glutamine deprivation induces ferroptosis in pancreatic cancer cells

Xianjun Yu, Chen Liu, Q. Ni, 2023, Acta biochimica et biophysica Sinica.

RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles

Feng Yang, C. Jin, D. Fu, 2009, Cancer biology & therapy.

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Zuqiang Liu, J. Long, Xianjun Yu, 2016, HPB.